AI regulatory submission software for pharma, biotech, and medical device teams.

📋 About

Assyro AI is an AI-native compliance platform for pharma and biotech regulatory operations. Teams spend 20-30% of their time compiling submissions across email, spreadsheets, and drives, driving eCTD errors, rejections, and resubmission delays that cost a program tens of millions. Assyro enforces regulatory rules in real time, auto-builds compliant multi-region eCTD packages, flags risks before filing, and submits automatically. The result: faster approvals, lower cost, less inspection risk.
🌐 Visit Website
Profile

Created by

welsenesbrothers

📊 Product Details

  • Status approved
  • Launch Date May 30, 2026
  • Upvotes 8
  • Featured No